Prista Charuworn

1.1k total citations
11 papers, 483 citations indexed

About

Prista Charuworn is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Prista Charuworn has authored 11 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Hepatology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Prista Charuworn's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (7 papers). Prista Charuworn is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (7 papers). Prista Charuworn collaborates with scholars based in United States, France and Canada. Prista Charuworn's co-authors include Patrick Marcellin, Eduardo B. Martins, Kathryn M. Kitrinos, Marı́a Buti, Raul Aguilar Schall, Naoky Tsai, G. Mani Subramanian, Edward Gane, John F. Flaherty and Selım Gürel and has published in prestigious journals such as Journal of Hepatology, Nature Reviews Gastroenterology & Hepatology and Digestive Diseases and Sciences.

In The Last Decade

Prista Charuworn

11 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prista Charuworn United States 6 297 274 144 134 66 11 483
Consuelo Comar Italy 5 232 0.8× 341 1.2× 57 0.4× 32 0.2× 50 0.8× 7 468
Elisabetta Pussini Italy 6 158 0.5× 319 1.2× 145 1.0× 124 0.9× 28 0.4× 9 443
Minas P. Economides United States 11 150 0.5× 148 0.5× 52 0.4× 44 0.3× 22 0.3× 27 344
Tung Ching Chan United States 4 440 1.5× 439 1.6× 44 0.3× 53 0.4× 35 0.5× 6 553
NE Traub United Kingdom 6 172 0.6× 187 0.7× 133 0.9× 80 0.6× 60 0.9× 8 355
Hannah Choi Canada 12 453 1.5× 346 1.3× 24 0.2× 32 0.2× 53 0.8× 14 599
M.-S. Dai Taiwan 5 266 0.9× 249 0.9× 29 0.2× 40 0.3× 21 0.3× 7 373
Grazia Careccia Italy 13 439 1.5× 524 1.9× 82 0.6× 61 0.5× 7 0.1× 14 616
M. G. Ferrari Italy 8 84 0.3× 89 0.3× 69 0.5× 71 0.5× 20 0.3× 9 333
Marta Caprioli Italy 7 101 0.3× 80 0.3× 32 0.2× 26 0.2× 32 0.5× 17 295

Countries citing papers authored by Prista Charuworn

Since Specialization
Citations

This map shows the geographic impact of Prista Charuworn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prista Charuworn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prista Charuworn more than expected).

Fields of papers citing papers by Prista Charuworn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prista Charuworn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prista Charuworn. The network helps show where Prista Charuworn may publish in the future.

Co-authorship network of co-authors of Prista Charuworn

This figure shows the co-authorship network connecting the top 25 collaborators of Prista Charuworn. A scholar is included among the top collaborators of Prista Charuworn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prista Charuworn. Prista Charuworn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Guttman‐Yassky, Emma, Eric L. Simpson, Ehsanollah Esfandiari, et al.. (2025). Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis. Dermatology and Therapy. 15(11). 3153–3171. 1 indexed citations
2.
Guttman‐Yassky, Emma, Eric L. Simpson, Robert Bissonnette, et al.. (2025). ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis. Immunotherapy. 17(2). 83–94. 5 indexed citations
3.
Awan, Farrukh T., Anna Schuh, Jennifer R. Brown, et al.. (2019). Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib. Blood Advances. 3(9). 1553–1562. 144 indexed citations
4.
Kadayıfçı, Abdurrahman, George Papatheodoridis, MF Yuen, et al.. (2015). Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB). Hepatology International. 1 indexed citations
5.
Chan, Henry Lik‐Yuen, Magdy Elkhashab, Huy N. Trinh, et al.. (2015). Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. Journal of Hepatology. 63(5). 1086–1092. 51 indexed citations
6.
Charuworn, Prista, Paul N. Hengen, Raul Aguilar Schall, et al.. (2014). Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate. Journal of Hepatology. 62(5). 1033–1039. 8 indexed citations
7.
Buti, Marı́a, Naoky Tsai, Joerg Petersen, et al.. (2014). Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection. Digestive Diseases and Sciences. 60(5). 1457–1464. 206 indexed citations
8.
Tsai, Naoky, Patrick Marcellin, Marı́a Buti, et al.. (2014). Viral Suppression and Cirrhosis Regression with Tenofovir Disoproxil Fumarate in Asians with Chronic Hepatitis B. Digestive Diseases and Sciences. 60(1). 260–268. 21 indexed citations
9.
Sklan, Ella H., et al.. (2009). Mechanisms of HCV survival in the host. Nature Reviews Gastroenterology & Hepatology. 6(4). 217–227. 41 indexed citations
10.
Charuworn, Prista & Emmet B. Keeffe. (2009). A review of the use of telbivudine in the treatment of chronic hepatitis B. 1. 4 indexed citations
11.
Charuworn, Prista & Ramsey Cheung. (2008). Diagnostic markers for hepatitis virus infection. Expert Opinion on Medical Diagnostics. 2(3). 303–314. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Consuelo Comar Breakdown of academic impact, for papers by Elisabetta Pussini Breakdown of academic impact, for papers by Minas P. Economides Breakdown of academic impact, for papers by Tung Ching Chan Breakdown of academic impact, for papers by NE Traub Breakdown of academic impact, for papers by Hannah Choi Breakdown of academic impact, for papers by M.-S. Dai Breakdown of academic impact, for papers by Grazia Careccia Breakdown of academic impact, for papers by M. G. Ferrari Breakdown of academic impact, for papers by Marta Caprioli
Rankless by CCL
2026